Quest Diagnostics
DGX
258.28
-0.81
-0.31%
Quest Diagnostics
US · DGX
#767 by market cap
Listed 1996
258.28
-0.81
-0.31%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
Company notice
GDEP Advance: 「NVIDIA DGX SuperPOD Specialization Partner」に認定JPX · 2025/11/5
-
Rating change
Truist Financial Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $260Market Newswire · 2026/9/21
-
Rating change
Morgan Stanley Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $260Market Newswire · 2026/10/23
-
Quest Diagnostics(DGX.US) Officer Sells US$3.06 Million in Common StockMarket Newswire · 2026/11/17
-
Mizuho Securities Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $260Market Newswire · 2026/11/17
-
Quest Diagnostics(DGX.US) Officer Sells US$5.48 Million in Common StockMarket Newswire · 2026/11/6
-
Rating change
J.P. Morgan Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $260Market Newswire · 2026/10/30
-
Rating change
Truist Financial Maintains Quest Diagnostics(DGX.US) With Hold Rating, Maintains Target Price $260Market Newswire · 2026/9/22
-
Rating change
UBS Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $250Market Newswire · 2026/10/19
-
Rating change
BofA Securities Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $265Market Newswire · 2026/10/23
-
Company notice
GDEP Advance: Announcements of individual stocks: Orders for the NVIDIA DGX B200 GPU Appliance Server, equipped with NVIDIA B200, have begun.JPX · 2024/7/29
-
Quest Diagnostics(DGX.US) Officer Sells US$3.02 Million in Common StockMarket Newswire · 2026/11/13
-
Company notice
Ryoyo Electro Corp: Lingyang Electronics begins to sell NVIDIA DGX Station (TM) A100, a new product of AI supercomputer.JPX · 2020/12/22
-
Company notice
HPC Systems: HPC Systems delivers NVIDIA DGX H100 to Fujikura Ltd., contributing to further acceleration of Fujikura's diverse AI technology developmentJPX · 2023/7/5
-
Rating change
Barclays Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $260Market Newswire · 2026/10/23
-
Rating change
Barclays Maintains Quest Diagnostics(DGX.US) With Buy Rating, Raises Target Price to $260Market Newswire · 2026/10/7
-
Rating change
Baird Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $262Market Newswire · 2026/10/23
-
Rating change
Barclays Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $250Market Newswire · 2026/9/23
-
Company notice
G-Next: Notice of Completion of Delivery of the Latest NVIDIA DGX B300 Blackwell GPU to Eleveight AI's AI Data Center, a Business Partner of G-NextJPX · 2026/3/24
-
Form 144 | Quest Diagnostics(DGX.US) Officer Proposes to Sell 3.02 Million in Common StocksMarket Newswire · 2026/11/9
-
Rating change
UBS Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $245Market Newswire · 2026/9/8
-
Rating change
Mizuho Securities Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $260Market Newswire · 2026/7/29
-
Form 144 | Quest Diagnostics(DGX.US) Officer Proposes to Sell 5.58 Million in Common StocksMarket Newswire · 2026/11/3
-
Rating change
Argus Research Maintains Quest Diagnostics(DGX.US) With Buy Rating, Raises Target Price to $260Market Newswire · 2026/7/29
-
Rating change
A Quick Look at Today's Ratings for Quest Diagnostics(DGX.US), With a Forecast Between $232 to $260Market Newswire · 2026/7/24
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:27 · For reference only, not investment advice and not tailored to your situation.
Quest Diagnostics discussion 0 comments